US Edition
Artificial Intelligence that Promises to Shorten the Wait for New Drugs
Summary by WWWhat's New
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A new approach developed by researchers at Simon Fraser University in Canada could dramatically change the process of drug discovery and manufacture, one of the most costly and slow tasks in the field of health. Under the name of CGFlow, this tool based on artificial intelligence not only designs therapeutic molecules, but also indicates the steps to make them in real laboratories.The bottleneck of the pharmaceutical industry Designing an effect…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
